Global Pirfenidone Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pirfenidone Industry Forecast” looks at past sales and reviews total world Pirfenidone sales in 2022, providing a comprehensive analysis by region and market sector of projected Pirfenidone sales for 2023 through 2029. With Pirfenidone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pirfenidone industry.
This Insight Report provides a comprehensive analysis of the global Pirfenidone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pirfenidone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pirfenidone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pirfenidone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pirfenidone.
The global Pirfenidone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pirfenidone players cover Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals and Koye Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pirfenidone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pirfenidone market?
What factors are driving Pirfenidone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pirfenidone market opportunities vary by end market size?
How does Pirfenidone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Pirfenidone Industry Forecast” looks at past sales and reviews total world Pirfenidone sales in 2022, providing a comprehensive analysis by region and market sector of projected Pirfenidone sales for 2023 through 2029. With Pirfenidone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pirfenidone industry.
This Insight Report provides a comprehensive analysis of the global Pirfenidone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pirfenidone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pirfenidone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pirfenidone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pirfenidone.
The global Pirfenidone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pirfenidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pirfenidone players cover Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals and Koye Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pirfenidone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Tablet
- Capsule
- Other
- Mild Idiopathic Pulmonary Fibrosis
- Moderate Idiopathic Pulmonary Fibrosis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Genentech (Roche)
- Shionogi
- GNI Group
- Beijing Continent
- Cipla
- Lupin Ltd
- Zydus Cadila
- Glenmark Pharmaceuticals
- Koye Pharmaceuticals
- MSN Laboratories
- Wockhardt
- Incepta Pharmaceuticals
- Unimed Unihealth
What is the 10-year outlook for the global Pirfenidone market?
What factors are driving Pirfenidone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pirfenidone market opportunities vary by end market size?
How does Pirfenidone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pirfenidone Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pirfenidone by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pirfenidone by Country/Region, 2018, 2022 & 2029
2.2 Pirfenidone Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Other
2.3 Pirfenidone Sales by Type
2.3.1 Global Pirfenidone Sales Market Share by Type (2018-2023)
2.3.2 Global Pirfenidone Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pirfenidone Sale Price by Type (2018-2023)
2.4 Pirfenidone Segment by Application
2.4.1 Mild Idiopathic Pulmonary Fibrosis
2.4.2 Moderate Idiopathic Pulmonary Fibrosis
2.4.3 Other
2.5 Pirfenidone Sales by Application
2.5.1 Global Pirfenidone Sale Market Share by Application (2018-2023)
2.5.2 Global Pirfenidone Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pirfenidone Sale Price by Application (2018-2023)
3 GLOBAL PIRFENIDONE BY COMPANY
3.1 Global Pirfenidone Breakdown Data by Company
3.1.1 Global Pirfenidone Annual Sales by Company (2018-2023)
3.1.2 Global Pirfenidone Sales Market Share by Company (2018-2023)
3.2 Global Pirfenidone Annual Revenue by Company (2018-2023)
3.2.1 Global Pirfenidone Revenue by Company (2018-2023)
3.2.2 Global Pirfenidone Revenue Market Share by Company (2018-2023)
3.3 Global Pirfenidone Sale Price by Company
3.4 Key Manufacturers Pirfenidone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pirfenidone Product Location Distribution
3.4.2 Players Pirfenidone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PIRFENIDONE BY GEOGRAPHIC REGION
4.1 World Historic Pirfenidone Market Size by Geographic Region (2018-2023)
4.1.1 Global Pirfenidone Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pirfenidone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pirfenidone Market Size by Country/Region (2018-2023)
4.2.1 Global Pirfenidone Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pirfenidone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pirfenidone Sales Growth
4.4 APAC Pirfenidone Sales Growth
4.5 Europe Pirfenidone Sales Growth
4.6 Middle East & Africa Pirfenidone Sales Growth
5 AMERICAS
5.1 Americas Pirfenidone Sales by Country
5.1.1 Americas Pirfenidone Sales by Country (2018-2023)
5.1.2 Americas Pirfenidone Revenue by Country (2018-2023)
5.2 Americas Pirfenidone Sales by Type
5.3 Americas Pirfenidone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pirfenidone Sales by Region
6.1.1 APAC Pirfenidone Sales by Region (2018-2023)
6.1.2 APAC Pirfenidone Revenue by Region (2018-2023)
6.2 APAC Pirfenidone Sales by Type
6.3 APAC Pirfenidone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pirfenidone by Country
7.1.1 Europe Pirfenidone Sales by Country (2018-2023)
7.1.2 Europe Pirfenidone Revenue by Country (2018-2023)
7.2 Europe Pirfenidone Sales by Type
7.3 Europe Pirfenidone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pirfenidone by Country
8.1.1 Middle East & Africa Pirfenidone Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pirfenidone Revenue by Country (2018-2023)
8.2 Middle East & Africa Pirfenidone Sales by Type
8.3 Middle East & Africa Pirfenidone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pirfenidone
10.3 Manufacturing Process Analysis of Pirfenidone
10.4 Industry Chain Structure of Pirfenidone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pirfenidone Distributors
11.3 Pirfenidone Customer
12 WORLD FORECAST REVIEW FOR PIRFENIDONE BY GEOGRAPHIC REGION
12.1 Global Pirfenidone Market Size Forecast by Region
12.1.1 Global Pirfenidone Forecast by Region (2024-2029)
12.1.2 Global Pirfenidone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pirfenidone Forecast by Type
12.7 Global Pirfenidone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Genentech (Roche)
13.1.1 Genentech (Roche) Company Information
13.1.2 Genentech (Roche) Pirfenidone Product Portfolios and Specifications
13.1.3 Genentech (Roche) Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Genentech (Roche) Main Business Overview
13.1.5 Genentech (Roche) Latest Developments
13.2 Shionogi
13.2.1 Shionogi Company Information
13.2.2 Shionogi Pirfenidone Product Portfolios and Specifications
13.2.3 Shionogi Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shionogi Main Business Overview
13.2.5 Shionogi Latest Developments
13.3 GNI Group
13.3.1 GNI Group Company Information
13.3.2 GNI Group Pirfenidone Product Portfolios and Specifications
13.3.3 GNI Group Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GNI Group Main Business Overview
13.3.5 GNI Group Latest Developments
13.4 Beijing Continent
13.4.1 Beijing Continent Company Information
13.4.2 Beijing Continent Pirfenidone Product Portfolios and Specifications
13.4.3 Beijing Continent Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Continent Main Business Overview
13.4.5 Beijing Continent Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Pirfenidone Product Portfolios and Specifications
13.5.3 Cipla Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Lupin Ltd
13.6.1 Lupin Ltd Company Information
13.6.2 Lupin Ltd Pirfenidone Product Portfolios and Specifications
13.6.3 Lupin Ltd Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lupin Ltd Main Business Overview
13.6.5 Lupin Ltd Latest Developments
13.7 Zydus Cadila
13.7.1 Zydus Cadila Company Information
13.7.2 Zydus Cadila Pirfenidone Product Portfolios and Specifications
13.7.3 Zydus Cadila Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zydus Cadila Main Business Overview
13.7.5 Zydus Cadila Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Koye Pharmaceuticals
13.9.1 Koye Pharmaceuticals Company Information
13.9.2 Koye Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Koye Pharmaceuticals Main Business Overview
13.9.5 Koye Pharmaceuticals Latest Developments
13.10 MSN Laboratories
13.10.1 MSN Laboratories Company Information
13.10.2 MSN Laboratories Pirfenidone Product Portfolios and Specifications
13.10.3 MSN Laboratories Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 MSN Laboratories Main Business Overview
13.10.5 MSN Laboratories Latest Developments
13.11 Wockhardt
13.11.1 Wockhardt Company Information
13.11.2 Wockhardt Pirfenidone Product Portfolios and Specifications
13.11.3 Wockhardt Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Wockhardt Main Business Overview
13.11.5 Wockhardt Latest Developments
13.12 Incepta Pharmaceuticals
13.12.1 Incepta Pharmaceuticals Company Information
13.12.2 Incepta Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Incepta Pharmaceuticals Main Business Overview
13.12.5 Incepta Pharmaceuticals Latest Developments
13.13 Unimed Unihealth
13.13.1 Unimed Unihealth Company Information
13.13.2 Unimed Unihealth Pirfenidone Product Portfolios and Specifications
13.13.3 Unimed Unihealth Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Unimed Unihealth Main Business Overview
13.13.5 Unimed Unihealth Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pirfenidone Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pirfenidone by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pirfenidone by Country/Region, 2018, 2022 & 2029
2.2 Pirfenidone Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Other
2.3 Pirfenidone Sales by Type
2.3.1 Global Pirfenidone Sales Market Share by Type (2018-2023)
2.3.2 Global Pirfenidone Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pirfenidone Sale Price by Type (2018-2023)
2.4 Pirfenidone Segment by Application
2.4.1 Mild Idiopathic Pulmonary Fibrosis
2.4.2 Moderate Idiopathic Pulmonary Fibrosis
2.4.3 Other
2.5 Pirfenidone Sales by Application
2.5.1 Global Pirfenidone Sale Market Share by Application (2018-2023)
2.5.2 Global Pirfenidone Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pirfenidone Sale Price by Application (2018-2023)
3 GLOBAL PIRFENIDONE BY COMPANY
3.1 Global Pirfenidone Breakdown Data by Company
3.1.1 Global Pirfenidone Annual Sales by Company (2018-2023)
3.1.2 Global Pirfenidone Sales Market Share by Company (2018-2023)
3.2 Global Pirfenidone Annual Revenue by Company (2018-2023)
3.2.1 Global Pirfenidone Revenue by Company (2018-2023)
3.2.2 Global Pirfenidone Revenue Market Share by Company (2018-2023)
3.3 Global Pirfenidone Sale Price by Company
3.4 Key Manufacturers Pirfenidone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pirfenidone Product Location Distribution
3.4.2 Players Pirfenidone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PIRFENIDONE BY GEOGRAPHIC REGION
4.1 World Historic Pirfenidone Market Size by Geographic Region (2018-2023)
4.1.1 Global Pirfenidone Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pirfenidone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pirfenidone Market Size by Country/Region (2018-2023)
4.2.1 Global Pirfenidone Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pirfenidone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pirfenidone Sales Growth
4.4 APAC Pirfenidone Sales Growth
4.5 Europe Pirfenidone Sales Growth
4.6 Middle East & Africa Pirfenidone Sales Growth
5 AMERICAS
5.1 Americas Pirfenidone Sales by Country
5.1.1 Americas Pirfenidone Sales by Country (2018-2023)
5.1.2 Americas Pirfenidone Revenue by Country (2018-2023)
5.2 Americas Pirfenidone Sales by Type
5.3 Americas Pirfenidone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pirfenidone Sales by Region
6.1.1 APAC Pirfenidone Sales by Region (2018-2023)
6.1.2 APAC Pirfenidone Revenue by Region (2018-2023)
6.2 APAC Pirfenidone Sales by Type
6.3 APAC Pirfenidone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pirfenidone by Country
7.1.1 Europe Pirfenidone Sales by Country (2018-2023)
7.1.2 Europe Pirfenidone Revenue by Country (2018-2023)
7.2 Europe Pirfenidone Sales by Type
7.3 Europe Pirfenidone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pirfenidone by Country
8.1.1 Middle East & Africa Pirfenidone Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pirfenidone Revenue by Country (2018-2023)
8.2 Middle East & Africa Pirfenidone Sales by Type
8.3 Middle East & Africa Pirfenidone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pirfenidone
10.3 Manufacturing Process Analysis of Pirfenidone
10.4 Industry Chain Structure of Pirfenidone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pirfenidone Distributors
11.3 Pirfenidone Customer
12 WORLD FORECAST REVIEW FOR PIRFENIDONE BY GEOGRAPHIC REGION
12.1 Global Pirfenidone Market Size Forecast by Region
12.1.1 Global Pirfenidone Forecast by Region (2024-2029)
12.1.2 Global Pirfenidone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pirfenidone Forecast by Type
12.7 Global Pirfenidone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Genentech (Roche)
13.1.1 Genentech (Roche) Company Information
13.1.2 Genentech (Roche) Pirfenidone Product Portfolios and Specifications
13.1.3 Genentech (Roche) Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Genentech (Roche) Main Business Overview
13.1.5 Genentech (Roche) Latest Developments
13.2 Shionogi
13.2.1 Shionogi Company Information
13.2.2 Shionogi Pirfenidone Product Portfolios and Specifications
13.2.3 Shionogi Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shionogi Main Business Overview
13.2.5 Shionogi Latest Developments
13.3 GNI Group
13.3.1 GNI Group Company Information
13.3.2 GNI Group Pirfenidone Product Portfolios and Specifications
13.3.3 GNI Group Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GNI Group Main Business Overview
13.3.5 GNI Group Latest Developments
13.4 Beijing Continent
13.4.1 Beijing Continent Company Information
13.4.2 Beijing Continent Pirfenidone Product Portfolios and Specifications
13.4.3 Beijing Continent Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Continent Main Business Overview
13.4.5 Beijing Continent Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Pirfenidone Product Portfolios and Specifications
13.5.3 Cipla Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Lupin Ltd
13.6.1 Lupin Ltd Company Information
13.6.2 Lupin Ltd Pirfenidone Product Portfolios and Specifications
13.6.3 Lupin Ltd Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lupin Ltd Main Business Overview
13.6.5 Lupin Ltd Latest Developments
13.7 Zydus Cadila
13.7.1 Zydus Cadila Company Information
13.7.2 Zydus Cadila Pirfenidone Product Portfolios and Specifications
13.7.3 Zydus Cadila Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zydus Cadila Main Business Overview
13.7.5 Zydus Cadila Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Koye Pharmaceuticals
13.9.1 Koye Pharmaceuticals Company Information
13.9.2 Koye Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Koye Pharmaceuticals Main Business Overview
13.9.5 Koye Pharmaceuticals Latest Developments
13.10 MSN Laboratories
13.10.1 MSN Laboratories Company Information
13.10.2 MSN Laboratories Pirfenidone Product Portfolios and Specifications
13.10.3 MSN Laboratories Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 MSN Laboratories Main Business Overview
13.10.5 MSN Laboratories Latest Developments
13.11 Wockhardt
13.11.1 Wockhardt Company Information
13.11.2 Wockhardt Pirfenidone Product Portfolios and Specifications
13.11.3 Wockhardt Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Wockhardt Main Business Overview
13.11.5 Wockhardt Latest Developments
13.12 Incepta Pharmaceuticals
13.12.1 Incepta Pharmaceuticals Company Information
13.12.2 Incepta Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Incepta Pharmaceuticals Main Business Overview
13.12.5 Incepta Pharmaceuticals Latest Developments
13.13 Unimed Unihealth
13.13.1 Unimed Unihealth Company Information
13.13.2 Unimed Unihealth Pirfenidone Product Portfolios and Specifications
13.13.3 Unimed Unihealth Pirfenidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Unimed Unihealth Main Business Overview
13.13.5 Unimed Unihealth Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pirfenidone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pirfenidone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Capsule
Table 5. Major Players of Other
Table 6. Global Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 7. Global Pirfenidone Sales Market Share by Type (2018-2023)
Table 8. Global Pirfenidone Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pirfenidone Revenue Market Share by Type (2018-2023)
Table 10. Global Pirfenidone Sale Price by Type (2018-2023) & (USD/Pcs)
Table 11. Global Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 12. Global Pirfenidone Sales Market Share by Application (2018-2023)
Table 13. Global Pirfenidone Revenue by Application (2018-2023)
Table 14. Global Pirfenidone Revenue Market Share by Application (2018-2023)
Table 15. Global Pirfenidone Sale Price by Application (2018-2023) & (USD/Pcs)
Table 16. Global Pirfenidone Sales by Company (2018-2023) & (K Pcs)
Table 17. Global Pirfenidone Sales Market Share by Company (2018-2023)
Table 18. Global Pirfenidone Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pirfenidone Revenue Market Share by Company (2018-2023)
Table 20. Global Pirfenidone Sale Price by Company (2018-2023) & (USD/Pcs)
Table 21. Key Manufacturers Pirfenidone Producing Area Distribution and Sales Area
Table 22. Players Pirfenidone Products Offered
Table 23. Pirfenidone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pirfenidone Sales by Geographic Region (2018-2023) & (K Pcs)
Table 27. Global Pirfenidone Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pirfenidone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pirfenidone Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pirfenidone Sales by Country/Region (2018-2023) & (K Pcs)
Table 31. Global Pirfenidone Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pirfenidone Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pirfenidone Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pirfenidone Sales by Country (2018-2023) & (K Pcs)
Table 35. Americas Pirfenidone Sales Market Share by Country (2018-2023)
Table 36. Americas Pirfenidone Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pirfenidone Revenue Market Share by Country (2018-2023)
Table 38. Americas Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 39. Americas Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 40. APAC Pirfenidone Sales by Region (2018-2023) & (K Pcs)
Table 41. APAC Pirfenidone Sales Market Share by Region (2018-2023)
Table 42. APAC Pirfenidone Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pirfenidone Revenue Market Share by Region (2018-2023)
Table 44. APAC Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 45. APAC Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 46. Europe Pirfenidone Sales by Country (2018-2023) & (K Pcs)
Table 47. Europe Pirfenidone Sales Market Share by Country (2018-2023)
Table 48. Europe Pirfenidone Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pirfenidone Revenue Market Share by Country (2018-2023)
Table 50. Europe Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 51. Europe Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Pirfenidone Sales by Country (2018-2023) & (K Pcs)
Table 53. Middle East & Africa Pirfenidone Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pirfenidone Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pirfenidone Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 57. Middle East & Africa Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 58. Key Market Drivers & Growth Opportunities of Pirfenidone
Table 59. Key Market Challenges & Risks of Pirfenidone
Table 60. Key Industry Trends of Pirfenidone
Table 61. Pirfenidone Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pirfenidone Distributors List
Table 64. Pirfenidone Customer List
Table 65. Global Pirfenidone Sales Forecast by Region (2024-2029) & (K Pcs)
Table 66. Global Pirfenidone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pirfenidone Sales Forecast by Country (2024-2029) & (K Pcs)
Table 68. Americas Pirfenidone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pirfenidone Sales Forecast by Region (2024-2029) & (K Pcs)
Table 70. APAC Pirfenidone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pirfenidone Sales Forecast by Country (2024-2029) & (K Pcs)
Table 72. Europe Pirfenidone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pirfenidone Sales Forecast by Country (2024-2029) & (K Pcs)
Table 74. Middle East & Africa Pirfenidone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pirfenidone Sales Forecast by Type (2024-2029) & (K Pcs)
Table 76. Global Pirfenidone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pirfenidone Sales Forecast by Application (2024-2029) & (K Pcs)
Table 78. Global Pirfenidone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Genentech (Roche) Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 80. Genentech (Roche) Pirfenidone Product Portfolios and Specifications
Table 81. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 82. Genentech (Roche) Main Business
Table 83. Genentech (Roche) Latest Developments
Table 84. Shionogi Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 85. Shionogi Pirfenidone Product Portfolios and Specifications
Table 86. Shionogi Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 87. Shionogi Main Business
Table 88. Shionogi Latest Developments
Table 89. GNI Group Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 90. GNI Group Pirfenidone Product Portfolios and Specifications
Table 91. GNI Group Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 92. GNI Group Main Business
Table 93. GNI Group Latest Developments
Table 94. Beijing Continent Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 95. Beijing Continent Pirfenidone Product Portfolios and Specifications
Table 96. Beijing Continent Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 97. Beijing Continent Main Business
Table 98. Beijing Continent Latest Developments
Table 99. Cipla Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 100. Cipla Pirfenidone Product Portfolios and Specifications
Table 101. Cipla Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 102. Cipla Main Business
Table 103. Cipla Latest Developments
Table 104. Lupin Ltd Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 105. Lupin Ltd Pirfenidone Product Portfolios and Specifications
Table 106. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 107. Lupin Ltd Main Business
Table 108. Lupin Ltd Latest Developments
Table 109. Zydus Cadila Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 110. Zydus Cadila Pirfenidone Product Portfolios and Specifications
Table 111. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 112. Zydus Cadila Main Business
Table 113. Zydus Cadila Latest Developments
Table 114. Glenmark Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 115. Glenmark Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 116. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 117. Glenmark Pharmaceuticals Main Business
Table 118. Glenmark Pharmaceuticals Latest Developments
Table 119. Koye Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 120. Koye Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 121. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Koye Pharmaceuticals Main Business
Table 123. Koye Pharmaceuticals Latest Developments
Table 124. MSN Laboratories Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 125. MSN Laboratories Pirfenidone Product Portfolios and Specifications
Table 126. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 127. MSN Laboratories Main Business
Table 128. MSN Laboratories Latest Developments
Table 129. Wockhardt Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 130. Wockhardt Pirfenidone Product Portfolios and Specifications
Table 131. Wockhardt Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 132. Wockhardt Main Business
Table 133. Wockhardt Latest Developments
Table 134. Incepta Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 135. Incepta Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 136. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 137. Incepta Pharmaceuticals Main Business
Table 138. Incepta Pharmaceuticals Latest Developments
Table 139. Unimed Unihealth Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 140. Unimed Unihealth Pirfenidone Product Portfolios and Specifications
Table 141. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Unimed Unihealth Main Business
Table 143. Unimed Unihealth Latest Developments
Table 1. Pirfenidone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pirfenidone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Capsule
Table 5. Major Players of Other
Table 6. Global Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 7. Global Pirfenidone Sales Market Share by Type (2018-2023)
Table 8. Global Pirfenidone Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pirfenidone Revenue Market Share by Type (2018-2023)
Table 10. Global Pirfenidone Sale Price by Type (2018-2023) & (USD/Pcs)
Table 11. Global Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 12. Global Pirfenidone Sales Market Share by Application (2018-2023)
Table 13. Global Pirfenidone Revenue by Application (2018-2023)
Table 14. Global Pirfenidone Revenue Market Share by Application (2018-2023)
Table 15. Global Pirfenidone Sale Price by Application (2018-2023) & (USD/Pcs)
Table 16. Global Pirfenidone Sales by Company (2018-2023) & (K Pcs)
Table 17. Global Pirfenidone Sales Market Share by Company (2018-2023)
Table 18. Global Pirfenidone Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pirfenidone Revenue Market Share by Company (2018-2023)
Table 20. Global Pirfenidone Sale Price by Company (2018-2023) & (USD/Pcs)
Table 21. Key Manufacturers Pirfenidone Producing Area Distribution and Sales Area
Table 22. Players Pirfenidone Products Offered
Table 23. Pirfenidone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pirfenidone Sales by Geographic Region (2018-2023) & (K Pcs)
Table 27. Global Pirfenidone Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pirfenidone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pirfenidone Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pirfenidone Sales by Country/Region (2018-2023) & (K Pcs)
Table 31. Global Pirfenidone Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pirfenidone Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pirfenidone Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pirfenidone Sales by Country (2018-2023) & (K Pcs)
Table 35. Americas Pirfenidone Sales Market Share by Country (2018-2023)
Table 36. Americas Pirfenidone Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pirfenidone Revenue Market Share by Country (2018-2023)
Table 38. Americas Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 39. Americas Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 40. APAC Pirfenidone Sales by Region (2018-2023) & (K Pcs)
Table 41. APAC Pirfenidone Sales Market Share by Region (2018-2023)
Table 42. APAC Pirfenidone Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pirfenidone Revenue Market Share by Region (2018-2023)
Table 44. APAC Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 45. APAC Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 46. Europe Pirfenidone Sales by Country (2018-2023) & (K Pcs)
Table 47. Europe Pirfenidone Sales Market Share by Country (2018-2023)
Table 48. Europe Pirfenidone Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pirfenidone Revenue Market Share by Country (2018-2023)
Table 50. Europe Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 51. Europe Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Pirfenidone Sales by Country (2018-2023) & (K Pcs)
Table 53. Middle East & Africa Pirfenidone Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pirfenidone Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pirfenidone Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pirfenidone Sales by Type (2018-2023) & (K Pcs)
Table 57. Middle East & Africa Pirfenidone Sales by Application (2018-2023) & (K Pcs)
Table 58. Key Market Drivers & Growth Opportunities of Pirfenidone
Table 59. Key Market Challenges & Risks of Pirfenidone
Table 60. Key Industry Trends of Pirfenidone
Table 61. Pirfenidone Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pirfenidone Distributors List
Table 64. Pirfenidone Customer List
Table 65. Global Pirfenidone Sales Forecast by Region (2024-2029) & (K Pcs)
Table 66. Global Pirfenidone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pirfenidone Sales Forecast by Country (2024-2029) & (K Pcs)
Table 68. Americas Pirfenidone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pirfenidone Sales Forecast by Region (2024-2029) & (K Pcs)
Table 70. APAC Pirfenidone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pirfenidone Sales Forecast by Country (2024-2029) & (K Pcs)
Table 72. Europe Pirfenidone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pirfenidone Sales Forecast by Country (2024-2029) & (K Pcs)
Table 74. Middle East & Africa Pirfenidone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pirfenidone Sales Forecast by Type (2024-2029) & (K Pcs)
Table 76. Global Pirfenidone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pirfenidone Sales Forecast by Application (2024-2029) & (K Pcs)
Table 78. Global Pirfenidone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Genentech (Roche) Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 80. Genentech (Roche) Pirfenidone Product Portfolios and Specifications
Table 81. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 82. Genentech (Roche) Main Business
Table 83. Genentech (Roche) Latest Developments
Table 84. Shionogi Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 85. Shionogi Pirfenidone Product Portfolios and Specifications
Table 86. Shionogi Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 87. Shionogi Main Business
Table 88. Shionogi Latest Developments
Table 89. GNI Group Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 90. GNI Group Pirfenidone Product Portfolios and Specifications
Table 91. GNI Group Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 92. GNI Group Main Business
Table 93. GNI Group Latest Developments
Table 94. Beijing Continent Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 95. Beijing Continent Pirfenidone Product Portfolios and Specifications
Table 96. Beijing Continent Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 97. Beijing Continent Main Business
Table 98. Beijing Continent Latest Developments
Table 99. Cipla Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 100. Cipla Pirfenidone Product Portfolios and Specifications
Table 101. Cipla Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 102. Cipla Main Business
Table 103. Cipla Latest Developments
Table 104. Lupin Ltd Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 105. Lupin Ltd Pirfenidone Product Portfolios and Specifications
Table 106. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 107. Lupin Ltd Main Business
Table 108. Lupin Ltd Latest Developments
Table 109. Zydus Cadila Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 110. Zydus Cadila Pirfenidone Product Portfolios and Specifications
Table 111. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 112. Zydus Cadila Main Business
Table 113. Zydus Cadila Latest Developments
Table 114. Glenmark Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 115. Glenmark Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 116. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 117. Glenmark Pharmaceuticals Main Business
Table 118. Glenmark Pharmaceuticals Latest Developments
Table 119. Koye Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 120. Koye Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 121. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Koye Pharmaceuticals Main Business
Table 123. Koye Pharmaceuticals Latest Developments
Table 124. MSN Laboratories Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 125. MSN Laboratories Pirfenidone Product Portfolios and Specifications
Table 126. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 127. MSN Laboratories Main Business
Table 128. MSN Laboratories Latest Developments
Table 129. Wockhardt Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 130. Wockhardt Pirfenidone Product Portfolios and Specifications
Table 131. Wockhardt Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 132. Wockhardt Main Business
Table 133. Wockhardt Latest Developments
Table 134. Incepta Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 135. Incepta Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 136. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 137. Incepta Pharmaceuticals Main Business
Table 138. Incepta Pharmaceuticals Latest Developments
Table 139. Unimed Unihealth Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 140. Unimed Unihealth Pirfenidone Product Portfolios and Specifications
Table 141. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Unimed Unihealth Main Business
Table 143. Unimed Unihealth Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pirfenidone
Figure 2. Pirfenidone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pirfenidone Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Pirfenidone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pirfenidone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Capsule
Figure 11. Product Picture of Other
Figure 12. Global Pirfenidone Sales Market Share by Type in 2022
Figure 13. Global Pirfenidone Revenue Market Share by Type (2018-2023)
Figure 14. Pirfenidone Consumed in Mild Idiopathic Pulmonary Fibrosis
Figure 15. Global Pirfenidone Market: Mild Idiopathic Pulmonary Fibrosis (2018-2023) & (K Pcs)
Figure 16. Pirfenidone Consumed in Moderate Idiopathic Pulmonary Fibrosis
Figure 17. Global Pirfenidone Market: Moderate Idiopathic Pulmonary Fibrosis (2018-2023) & (K Pcs)
Figure 18. Pirfenidone Consumed in Other
Figure 19. Global Pirfenidone Market: Other (2018-2023) & (K Pcs)
Figure 20. Global Pirfenidone Sales Market Share by Application (2022)
Figure 21. Global Pirfenidone Revenue Market Share by Application in 2022
Figure 22. Pirfenidone Sales Market by Company in 2022 (K Pcs)
Figure 23. Global Pirfenidone Sales Market Share by Company in 2022
Figure 24. Pirfenidone Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Pirfenidone Revenue Market Share by Company in 2022
Figure 26. Global Pirfenidone Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Pirfenidone Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Pirfenidone Sales 2018-2023 (K Pcs)
Figure 29. Americas Pirfenidone Revenue 2018-2023 ($ Millions)
Figure 30. APAC Pirfenidone Sales 2018-2023 (K Pcs)
Figure 31. APAC Pirfenidone Revenue 2018-2023 ($ Millions)
Figure 32. Europe Pirfenidone Sales 2018-2023 (K Pcs)
Figure 33. Europe Pirfenidone Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Pirfenidone Sales 2018-2023 (K Pcs)
Figure 35. Middle East & Africa Pirfenidone Revenue 2018-2023 ($ Millions)
Figure 36. Americas Pirfenidone Sales Market Share by Country in 2022
Figure 37. Americas Pirfenidone Revenue Market Share by Country in 2022
Figure 38. Americas Pirfenidone Sales Market Share by Type (2018-2023)
Figure 39. Americas Pirfenidone Sales Market Share by Application (2018-2023)
Figure 40. United States Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Pirfenidone Sales Market Share by Region in 2022
Figure 45. APAC Pirfenidone Revenue Market Share by Regions in 2022
Figure 46. APAC Pirfenidone Sales Market Share by Type (2018-2023)
Figure 47. APAC Pirfenidone Sales Market Share by Application (2018-2023)
Figure 48. China Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Pirfenidone Sales Market Share by Country in 2022
Figure 56. Europe Pirfenidone Revenue Market Share by Country in 2022
Figure 57. Europe Pirfenidone Sales Market Share by Type (2018-2023)
Figure 58. Europe Pirfenidone Sales Market Share by Application (2018-2023)
Figure 59. Germany Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Pirfenidone Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Pirfenidone Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Pirfenidone Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Pirfenidone Sales Market Share by Application (2018-2023)
Figure 68. Egypt Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Pirfenidone in 2022
Figure 74. Manufacturing Process Analysis of Pirfenidone
Figure 75. Industry Chain Structure of Pirfenidone
Figure 76. Channels of Distribution
Figure 77. Global Pirfenidone Sales Market Forecast by Region (2024-2029)
Figure 78. Global Pirfenidone Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Pirfenidone Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Pirfenidone Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Pirfenidone Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Pirfenidone Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pirfenidone
Figure 2. Pirfenidone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pirfenidone Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Pirfenidone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pirfenidone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Capsule
Figure 11. Product Picture of Other
Figure 12. Global Pirfenidone Sales Market Share by Type in 2022
Figure 13. Global Pirfenidone Revenue Market Share by Type (2018-2023)
Figure 14. Pirfenidone Consumed in Mild Idiopathic Pulmonary Fibrosis
Figure 15. Global Pirfenidone Market: Mild Idiopathic Pulmonary Fibrosis (2018-2023) & (K Pcs)
Figure 16. Pirfenidone Consumed in Moderate Idiopathic Pulmonary Fibrosis
Figure 17. Global Pirfenidone Market: Moderate Idiopathic Pulmonary Fibrosis (2018-2023) & (K Pcs)
Figure 18. Pirfenidone Consumed in Other
Figure 19. Global Pirfenidone Market: Other (2018-2023) & (K Pcs)
Figure 20. Global Pirfenidone Sales Market Share by Application (2022)
Figure 21. Global Pirfenidone Revenue Market Share by Application in 2022
Figure 22. Pirfenidone Sales Market by Company in 2022 (K Pcs)
Figure 23. Global Pirfenidone Sales Market Share by Company in 2022
Figure 24. Pirfenidone Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Pirfenidone Revenue Market Share by Company in 2022
Figure 26. Global Pirfenidone Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Pirfenidone Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Pirfenidone Sales 2018-2023 (K Pcs)
Figure 29. Americas Pirfenidone Revenue 2018-2023 ($ Millions)
Figure 30. APAC Pirfenidone Sales 2018-2023 (K Pcs)
Figure 31. APAC Pirfenidone Revenue 2018-2023 ($ Millions)
Figure 32. Europe Pirfenidone Sales 2018-2023 (K Pcs)
Figure 33. Europe Pirfenidone Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Pirfenidone Sales 2018-2023 (K Pcs)
Figure 35. Middle East & Africa Pirfenidone Revenue 2018-2023 ($ Millions)
Figure 36. Americas Pirfenidone Sales Market Share by Country in 2022
Figure 37. Americas Pirfenidone Revenue Market Share by Country in 2022
Figure 38. Americas Pirfenidone Sales Market Share by Type (2018-2023)
Figure 39. Americas Pirfenidone Sales Market Share by Application (2018-2023)
Figure 40. United States Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Pirfenidone Sales Market Share by Region in 2022
Figure 45. APAC Pirfenidone Revenue Market Share by Regions in 2022
Figure 46. APAC Pirfenidone Sales Market Share by Type (2018-2023)
Figure 47. APAC Pirfenidone Sales Market Share by Application (2018-2023)
Figure 48. China Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Pirfenidone Sales Market Share by Country in 2022
Figure 56. Europe Pirfenidone Revenue Market Share by Country in 2022
Figure 57. Europe Pirfenidone Sales Market Share by Type (2018-2023)
Figure 58. Europe Pirfenidone Sales Market Share by Application (2018-2023)
Figure 59. Germany Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Pirfenidone Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Pirfenidone Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Pirfenidone Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Pirfenidone Sales Market Share by Application (2018-2023)
Figure 68. Egypt Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Pirfenidone Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Pirfenidone in 2022
Figure 74. Manufacturing Process Analysis of Pirfenidone
Figure 75. Industry Chain Structure of Pirfenidone
Figure 76. Channels of Distribution
Figure 77. Global Pirfenidone Sales Market Forecast by Region (2024-2029)
Figure 78. Global Pirfenidone Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Pirfenidone Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Pirfenidone Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Pirfenidone Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Pirfenidone Revenue Market Share Forecast by Application (2024-2029)
